Top

Published in:

01-12-2013 | News item

EMA to listen to patients' voice when assessing meds

Published in: Reactions Weekly | Issue 1/2013

Excerpt

Patient involvement in the assessment of medicines, especially patient-perceived risk benefit analysis, is an area marked for further development, according to a published report from an EMA workshop titled `The patient's voice in the evaluation of medicines'.1, 2 …

EMA. European Medicines Agency explores ways to further involve patients in the benefit-risk assessment of medicines. Internet Document : 29 Oct 2013. Available from: URL: http://www.ema.europa.eu

EMA. The patient's voice in the evaluation of medicines -- How patients can contribute to assessment of benefit and risk. Internet Document : [7 pages], 18 Oct 2013. Available from: URL: http://www.ema.europa.eu

Title: EMA to listen to patients' voice when assessing meds
Publication date: 01-12-2013
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2013
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-013-7678-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

EMA to listen to patients' voice when assessing meds

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2013

Vemurafenib

Metronidazole

Infliximab

Vemurafenib

Carbamazepine

Paclitaxel